论文部分内容阅读
目的研究胸腔镜下肺叶切除术在治疗肺癌中的临床应用价值。方法 64例肺癌患者作为研究对象,随机分为胸腔镜组(观察组)和传统开胸组(对照组),各32例。观察两组患者的手术时间、术中出血量、清扫淋巴结数目、胸腔引流管留置时间、术后并发症、术后住院时间及1年无瘤生存率,采用视觉模拟评分法(VAS)评价术后切口疼痛情况。结果两组患者手术均获得成功。观察组术中出血量、胸腔引流管留置时间、术后住院时间、术后VAS评分均优于对照组,差异有统计学意义(P<0.05)。两组手术时间、术中淋巴结清扫数目比较,差异无统计学意义(P>0.05)。观察组与对照组1年无瘤生存率分别为96.88%、93.75%,比较差异无统计学意义(P>0.05)。观察组并发症发生率为12.50%,明显低于对照组的34.38%,差异有统计学意义(P<0.05)。结论胸腔镜下肺叶切除术治疗肺癌具有传统开胸手术所没有的独特优势,具有创伤小、出血量少、住院时间短、疼痛轻等优点,是一种安全、有效、微创的肺癌治疗方法 ,值得临床推广应用。
Objective To study the clinical value of thoracoscopic lobectomy in the treatment of lung cancer. Methods Sixty-four patients with lung cancer were randomly divided into thoracoscope group (observation group) and conventional thoracotomy group (control group), with 32 cases in each group. The operation time, intraoperative blood loss, the number of lymph nodes dissected, the drainage time of thoracic drainage tube, postoperative complications, postoperative hospital stay and 1-year disease-free survival rate were observed. Visual analogue scale (VAS) Post incision pain situation. Results The operation of both groups was successful. The blood loss in the observation group, the placement time of the thoracic drainage tube, postoperative hospital stay and VAS score were all better than those in the control group (P <0.05). There was no significant difference in the operation time and the number of lymph node dissection between the two groups (P> 0.05). The 1-year disease-free survival rates of the observation group and the control group were 96.88% and 93.75% respectively, with no significant difference (P> 0.05). The incidence of complications in the observation group was 12.50%, which was significantly lower than that in the control group (34.38%), the difference was statistically significant (P <0.05). Conclusions Thoracoscopic lobectomy is a safe, effective and minimally invasive method for the treatment of lung cancer with the unique advantages of no traditional thoracotomy. It has the advantages of less trauma, less blood loss, shorter hospital stay and less pain. ,Worthy of clinical application.